CRISPR Therapeutics AG Growth Metrics (2015-2026) | CRSP

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Growth Metrics	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Growth Ratios
EBITDA Margin Growth (1y) (Quarter)	4.68M	2.80M	0.25M	-11.61M	-17.84M	-219.12M	1.87M	11.59M		219.24M	-2.78M	-2.91M		-0.02M	1.07M	0.35M	0.34M	-1.77M	0.82M	2.46M
EBITDA Margin Growth (3y) (Quarter)	-0.69M	3.82M	-0.40M	-9.87M	-19.41M	-219.24M	4.68M	18.32M		2.92M	-0.66M	-2.93M	-0.27M	0.09M	0.16M	9.03M	17.92M	217.44M	-0.89M	-0.10M
EBITDA Margin Growth (5y) (Quarter)	-1.47M	-0.00M	-1.80M	-11.54M	-19.30M	-219.24M	0.19M	0.33M		3.94M	-1.31M	-1.20M	-1.84M	-0.02M	2.97M	15.77M	4.76M	1.12M	1.23M	-0.12M
EBITDA Margin (QoQ) (Quarter)	-1.57M	1.45M	-1.76M	-9.73M	-7.80M	-199.83M	219.23M	-0.01M			-2.79M	-0.14M	1.10M	1.81M	-1.70M	-0.86M	1.09M	-0.31M	0.90M	0.78M
EBIT Margin Growth (1y) (Quarter)	4.68M	2.80M	0.25M	-11.61M	-17.84M	-219.12M	1.87M	11.59M		219.24M	-2.78M	-2.91M		-0.02M	1.07M	0.35M	0.34M	-1.77M	0.82M	2.46M
EBIT Margin Growth (3y) (Quarter)	-0.69M	3.82M	-0.40M	-9.87M	-19.41M	-219.24M	4.68M	18.32M		2.92M	-0.66M	-2.93M	-0.27M	0.09M	0.16M	9.03M	17.92M	217.44M	-0.89M	-0.10M
EBIT Margin Growth (5y) (Quarter)	-1.47M	-0.00M	-1.80M	-11.54M	-19.30M	-219.24M	0.19M	0.33M		3.94M	-1.31M	-1.20M	-1.84M	-0.02M	2.97M	15.77M	4.76M	1.12M	1.23M	-0.12M
EBIT Margin (QoQ) (Quarter)	-1.57M	1.45M	-1.76M	-9.73M	-7.80M	-199.83M	219.23M	-0.01M			-2.79M	-0.14M	1.10M	1.81M	-1.70M	-0.86M	1.09M	-0.31M	0.90M	0.78M
EBT Margin Growth (1y) (Quarter)	4.68M	2.99M	0.22M	-11.38M	-17.08M	-199.97M	1.86M	11.36M		200.09M	-2.29M	-2.41M		0.10M	0.74M	0.10M	0.22M	-1.98M	0.72M	2.23M
EBT Margin Growth (3y) (Quarter)	-0.65M	4.01M	-0.39M	-9.69M	-18.64M	-200.09M	4.41M	18.01M		3.11M	-0.21M	-2.43M	0.14M	0.21M	0.31M	9.05M	17.44M	198.20M	-0.83M	-0.08M
EBT Margin Growth (5y) (Quarter)	-1.46M	-0.19M	-1.79M	-11.31M	-18.53M	-200.09M	0.20M	0.34M		4.12M	-0.83M	-0.73M	-1.42M	0.10M	2.86M	15.69M	5.04M	1.22M	1.25M	-0.10M
EBT Margin (QoQ) (Quarter)	-1.56M	1.44M	-1.76M	-9.51M	-7.26M	-181.45M	200.08M	-0.01M			-2.30M	-0.12M	1.01M	1.52M	-1.66M	-0.76M	1.13M	-0.69M	1.04M	0.75M
Enterprise Value Growth (1y) (Quarter)	-81.36%	-40.75%	-22.98%	20.24%	23.47%	23.70%	15.22%	14.39%	8.24%	6.70%	-11.95%	-13.21%	-11.26%	5.20%	11.99%	14.01%	1.03%	-23.06%	-31.61%	-37.36%
Enterprise Value Growth (3y) (Quarter)	-71.95%	-73.36%	-71.87%	-69.00%	-44.40%	-24.36%	-28.39%	-23.22%	-8.40%	-0.07%	-5.29%	8.22%	7.90%	12.29%	5.82%	5.89%	-0.35%	-2.86%	-9.05%	-10.17%
Enterprise Value Growth (5y) (Quarter)	-61.05%	-49.49%	-50.05%	-49.62%	-49.17%	-49.91%	-40.68%	-40.78%	-28.99%	-29.97%	-36.95%	-36.15%	-25.18%	-11.21%	-15.83%	-12.74%	-7.00%	-3.17%	-6.22%	1.80%
Enterprise Value (QoQ) (Quarter)	4.33%	3.97%	6.64%	7.02%	8.20%	4.25%	-3.74%	6.11%	1.60%	2.65%	-24.47%	5.05%	3.30%	17.05%	-15.55%	7.23%	-11.30%	-3.14%	-23.58%	3.17%
FCF Margin Growth (1y) (Quarter)	3.70M	2.54M	0.53M	-10.20M	-7.62M	-184.14M	1.50M	10.17M		184.21M	2.16M	-1.84M		-0.01M	-2.79M	0.58M	0.83M	-1.06M	-0.12M	1.20M
FCF Margin Growth (3y) (Quarter)	-1.05M	2.27M	-0.15M	-8.96M	-9.07M	-184.22M	3.51M	6.54M		2.61M	4.20M	-1.87M	-0.34M	0.06M	0.88M	8.91M	8.11M	183.14M	-0.75M	-0.06M
FCF Margin Growth (5y) (Quarter)	-1.36M	0.01M	-1.41M	-10.14M	-8.98M	-184.21M	0.17M	0.21M		2.34M	3.51M	-0.63M	-1.79M	-0.01M	2.89M	5.28M	4.18M	1.54M	1.28M	-0.09M
FCF Margin (QoQ) (Quarter)	-1.45M	1.36M	-1.43M	-8.69M	1.13M	-175.16M	184.22M	-0.02M			2.17M	-4.03M	0.08M	1.77M	-0.61M	-0.65M	0.33M	-0.12M	0.33M	0.67M
Interest Coverage Ratio Growth (1y) (Quarter)	77.54%	-453.32%	94.98%	-100.91%	93.88%	0.23%	41.63%	-11.48%	-127.33%	190.67%	-715.34%	-324.64%	-2,454.49%	-864.25%		-1,027.33%	-160.19%	-17,076.65%
Interest Coverage Ratio Growth (3y) (Quarter)	-638.40%	90.92%	-180.23%	-201.80%	-108.40%	-28.55%			68.50%	91.34%	37.97%	-26.89%	-52.59%	-90.50%		-276.50%	-432.62%	-959.77%	-13.84%	5.55%
Interest Coverage Ratio Growth (5y) (Quarter)	-191.37%	-7.24%	50.54%	58.07%	-64.31%	-114.83%	-109.57%	-129.48%	-123.68%	14.88%	-153.52%	-164.78%	-233.33%	-23.40%			-15.73%	-480.12%	46.65%	-14.97%
Interest Coverage Ratio (QoQ) (Quarter)	-113.61%	99.51%	-1,465.39%	13.10%	8.85%	91.95%	-815.82%	-65.99%	-85.86%	103.21%	-8,335.53%	13.55%	-1,018.08%	99.04%			-158.05%	36.62%	98.86%	5.22%
Net Margin Growth (1y) (Quarter)	4.70M	2.99M	0.19M	-11.77M	-17.03M	-184.18M	1.90M	11.75M		184.30M	-2.31M	-2.43M		0.10M	0.74M	0.11M	0.23M	-1.98M	0.73M	2.25M
Net Margin Growth (3y) (Quarter)	-0.64M	4.03M	-0.43M	-10.07M	-18.58M	-184.30M	4.44M	18.10M		3.10M	-0.21M	-2.45M	0.12M	0.21M	0.33M	9.42M	17.37M	182.41M	-0.84M	-0.08M
Net Margin Growth (5y) (Quarter)	-1.45M	-0.18M	-1.83M	-11.70M	-18.47M	-184.29M	0.20M	0.34M		4.14M	-0.84M	-0.76M	-1.43M	0.10M	2.87M	15.77M	5.05M	1.22M	1.26M	-0.10M
Net Margin (QoQ) (Quarter)	-1.55M	1.43M	-1.80M	-9.85M	-6.81M	-165.72M	184.29M	-0.01M			-2.32M	-0.13M	1.02M	1.53M	-1.67M	-0.77M	1.14M	-0.68M	1.03M	0.75M
Operating Margin Growth (1y) (Quarter)	4.68M	2.80M	0.25M	-11.61M	-17.84M	-219.12M	1.87M	11.59M		219.24M	-2.78M	-2.91M		-0.02M	1.07M	0.35M	0.34M	-1.77M	0.82M	2.46M
Operating Margin Growth (3y) (Quarter)	-0.69M	3.82M	-0.40M	-9.87M	-19.41M	-219.24M	4.68M	18.32M		2.92M	-0.66M	-2.93M	-0.27M	0.09M	0.16M	9.03M	17.92M	217.44M	-0.89M	-0.10M
Operating Margin Growth (5y) (Quarter)	-1.47M	-0.00M	-1.80M	-11.54M	-19.30M	-219.24M	0.19M	0.33M		3.94M	-1.31M	-1.20M	-1.84M	-0.02M	2.97M	15.77M	4.76M	1.12M	1.23M	-0.12M
Operating Margin (QoQ) (Quarter)	-1.57M	1.45M	-1.76M	-9.73M	-7.80M	-199.83M	219.23M	-0.01M			-2.79M	-0.14M	1.10M	1.81M	-1.70M	-0.86M	1.09M	-0.31M	0.90M	0.78M
Return on Assets Growth (1y) (Quarter)	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Return on Assets Growth (3y) (Quarter)	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Return on Assets Growth (5y) (Quarter)		0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Return on Assets (QoQ) (Quarter)	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Return on Capital Employed Growth (1y) (Quarter)	0.00M	0.00M	0.00M	-0.00M	-0.00M	-0.00M	-0.00M	356.00	958.00	0.00M	0.00M	700.00	581.00	-0.00M	-928.00	-0.00M	-0.00M	-997.00	-464.00	680.00
Return on Capital Employed Growth (3y) (Quarter)	0.00M	0.00M	0.01M	0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-92.00	0.00M	837.00	-0.00M	-0.00M	-0.00M	-0.00M	-147.00	199.00	-63.00	-61.00	178.00
Return on Capital Employed Growth (5y) (Quarter)		0.00M	0.00M	128.00	185.00	-628.00	-380.00	247.00	706.00	0.00M	0.00M	0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-851.00	-887.00	-555.00	-0.00M
Return on Capital Employed (QoQ) (Quarter)	-435.00	-88.00	-184.00	-0.00M	-420.00	-47.00	413.00	410.00	182.00	0.00M	-262.00	-220.00	63.00	-653.00	-117.00	-496.00	-74.00	-310.00	416.00	649.00
Return on Sales Growth (1y) (Quarter)	470.00	299.00	19.00	-0.00M	-0.00M	-0.02M	190.00	0.00M	0.00M	0.02M	-231.00	-243.00	-141.00	10.00	74.00	11.00	23.00	-198.00	73.00	225.00
Return on Sales Growth (3y) (Quarter)	-64.00	403.00	-43.00	-0.00M	-0.00M	-0.02M	444.00	0.00M	623.00	310.00	-21.00	-245.00	12.00	21.00	33.00	942.00	0.00M	0.02M	-84.00	-8.00
Return on Sales Growth (5y) (Quarter)	-145.00	-18.00	-183.00	-0.00M	-0.00M	-0.02M	20.00	34.00	88.00	414.00	-84.00	-76.00	-143.00	10.00	287.00	0.00M	505.00	122.00	126.00	-10.00
Return on Sales (QoQ) (Quarter)	-155.00	143.00	-180.00	-985.00	-681.00	-0.02M	0.02M	-1.00	-1.00	3.00	-232.00	-13.00	102.00	153.00	-167.00	-77.00	114.00	-68.00	103.00	75.00

Research Tools

Datasets

Plans

Developers

CRISPR Therapeutics AG Growth Metrics (2015-2026) | CRSP

Research Tools

Datasets

Plans

Developers

CRISPR Therapeutics AG Growth Metrics (2015-2026) | CRSP

Create an account

Sign In

Reset Password